4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001714899-24-000197
President and CEO sold 2,260 shares at $23.79 ($53,765)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Watts Ryan J. President and CEO | 2024-08-20 | Sale | −2,260 | $23.79 | $53,765 | 235,807 | D |
| Open-market sales · 2,260 sh · avg $23.79 · $53,765 | |||||||
Loading xslF345X05/wk-form4_1724357777.xml…